Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Featured News     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks General Information Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Featured News Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

China's Healthcare Reform to Center on Public Hospital Reform in the New Year Chief Editor James Shen offers his regular monthly review of the Chinese healthcare sector with this month's emphasis on China's proposed amendment of drug registration r... (2/22/2014) What Money Failed To Buy: The Limits Of China's Healthcare Reform (3/5/2014) Improved Prescribing and Reimbursement Practices in Ningxia Pay-for-performance Trial (3/3/2014) China's Healthcare Reform to Center on Public Hospital Reform in the New Year (2/22/2014) The Ethical Challenges of Doing Business in China's Healthcare Economy (External) (2/12/2014) Why Did One Of The World's Largest Generic Drug Makers Exit China? (External) (2/6/2014) Will the Lucky Green Wooden Horse of 2014 Save the Day? (1/22/2014) Review of Chinese Pharma Deals, R&D and Regulatory Developments in 2013 (1/20/2014) Hospital Drug Consumption in Yangtze River Vicinity 2008-2012 (1/20/2014) Western Scientists Look To Chinese Medicine For Fresh Leads (External) (1/20/2014) Will GSK's Incentive Compensation and Speaker Program Initiatives Set the Tone for 2014? (External) (1/10/2014) China Tops Europe in R&D Intensity (External) (1/10/2014) (free) China Obsessed with Cost Containment despite Huge BMI Surpluses (1/8/2014) Pharma's Wild Ride in China (External) (1/6/2014) Legal Experts Highlight New Chinese Regulations on Blacklisting and Compliance (1/3/2014) (free) Changing R&D and Manufacturing Strategies for MNCs in China (12/23/2013) China under Threat of Intensifying Docto...  (3/7/2014) (free) Upcoming Event: Simon-Kucher Life Scienc...  (3/7/2014) (free) Upcoming Event: Pharma Business Developm...  (3/6/2014) (free) Chinese M&A Trended Down in Febr...  (3/6/2014) Upcoming Event: Pharma China Seminar 201...  (3/6/2014) (free) Upcoming Event: Pharma China Annual Foru...  (3/6/2014) (free) Biostar Partners with Shaanxi University...  (3/6/2014) Lilly and Novast Expands Joint Facility ...  (3/5/2014) CFDA Suspends 1,000 Pharma Businesses in...  (3/5/2014) (free) NDRC to Push Forward Drug Pricing Reform...  (3/5/2014) Pharma Industry Delegates Renews Attack ...  (3/5/2014) Executive Moves  (3/4/2014) CDE Review of Class 1 New Drug Applicati...  (3/2/2014) NDRC Solicits Local Government Comments ...  (3/2/2014) Shanghai Pudong Seeks to Become CMO Tria...  (3/2/2014) IMS: Global Spending on Medicines to Reach $1.2 Trillion... Mergermarket: Global Pharma M&A Activity Fell Slight... GlaxoSmithKline Pledges to Stop Paying Doctors to Promot... India to Launch New Measure to Restrict Foreign Investme... Patheon, DSM to Merge Pharmaceutical Business APAC Epilepsy Therapeutics Market to Surge 4.7% CAGR by 2019 Chinese Foreign Trade of Medicines and Health Products Maintain... MNCs Dominate the Chinese Ophthalmology Drug Market Nicholas Hall Reports Slower Growth of OTC Gastrointestinal Mar... Data Snapshot: Top 10 Drugs in Representative Shanghai Hospital... Chinese M&A Trended Down in February with Healthcare... Biostar Partners with Shaanxi University of TCM to Develop A... Lilly and Novast Expands Joint Facility in Nantong for Lilly... Pharma Industry Delegates Renews Attack of the Centralized D... Guangzhou Pharmaceutical Group to Step Up Acquisitions for A... CFDA Suspends 1,000 Pharma Businesses in Illegal Drug Cr... NDRC to Push Forward Drug Pricing Reform after the "Two ... NDRC Solicits Local Government Comments on Liberalizing ... Shanghai Pudong Seeks to Become CMO Trial Site CFDA Issues Guidelines for GSP Onsite Inspections SIPO Clarifies Supplemental Evidence in Pharmaceutical Paten... China Sentences Physicians and Medical Reps for Drug Sales K... Former SinoPharm VP Detained for Corruption-related Accusati... USTR Releases 2013 Report on China's WTO Compliance Highligh... Chinese Police Arrests 1,300 People for Illegal Online Drug ... EU Lifts Anti-dumpling Duties on API Dicyandiamide Dishman Looks to Sell Its Newly-completed API Facility i... Hainan Shuangcheng Passes cGMP Certification of USFDA ScinoPharm Completes Its Changshu Plant in Jiangsu Provi... EU Revokes CEPs of Three APIs of Suzhou No.4 Pharma CDE Review of Class 1 New Drug Applications Nearly Doubl... Shanghai Anew Pharma Completes Preclinical Study of Onco... iBio Granted Chinese Patent for HPV-related Cancer Vacci... Third Clinical Trial Application for H7N9 Vaccine Filed ... Suven Granted Additional Patents in China for Its CNS Dr... China under Threat of Intensifying Doctor-Patient Confli... Zhejiang Announces Centralized Hospital Drug Purchase Da... National Children's Medical Center to be Established in ... Zhejiang Plans Separation of Drug Sales and Medical Serv... NHFPC Announces Key Tasks for Health and Family Planning... Executive Moves Executive Moves PKU Pharmacologists Invited to Become Leading Journal Edit... Recent Executive Moves CFDA Announces Appointment of Numerous Senior Officials Upcoming Event: Simon-Kucher Life Sciences China Forum Upcoming Event: Pharma Business Development Course Upcoming Event: Pharma China Seminar 2014 in NJ on April... Upcoming Event: Pharma China Annual Forum 2014 on April ... NHFPC Vice Minister MA Xiaowei Meets PhRMA Delegation Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON Officially Publishes Its...   WiCON Publishes China Pharmace...   WiCON officially publishes Chi...   Pharma China adds one more dis...   Pharma China adds another dist...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links